Skip to main content
See every side of every news story
Published loading...Updated

Over 25% of Ocular Complications From Dupilumab in Kids Developed After a Year

Summary by MedPage Today
(MedPage Today) -- ORLANDO -- Among children taking the monoclonal antibody dupilumab (Dupixent) for atopic dermatitis, more than a quarter of ocular complications developed after a year, according to a retrospective cohort study. Of the children...

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Anti-Aging, Acupuncture and Health News broke the news in on Wednesday, October 22, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal